Objective: This study aimed to investigate death anxiety and fear of Covid-19 in patients with schizophrenia and bipolar affective disorder (BAD) during the Covid-19 pandemic.

Materials and Methods: A total of 212 participants (72 schizophrenia, 70 BAD, 70 controls) were included in the study. Interviews with the participants were held face-to-face in July 2021.

Results: In the BAD group and control group Templer Death Anxiety Scale (TDAS) scores were higher than the TDAS scores of the schizophrenia group. The Covid-19 Fear Scale scores of the BAD group and control group were higher than the Covid-19 Fear Scale scores of the schizophrenia group. There was a positive correlation between the schizophrenia group Positive and Negative Syndrome Scale total scores, positive subscale scores and TDAS scores; and positive subscale scores and Covid-19 Fear Scale scores. There was a positive correlation between the Young Mania Rating Scale scores of the BAD group and TDAS and Covid-19 Fear Scale scores. Those with shorter disease duration in the schizophrenia group had higher TDAS scores. Those with a history of Covid-19 in the BAD group had higher TDAS and Covid-19 Fear Scale scores.

Conclusion: In the Covid-19 pandemic, it will be beneficial to investigate death anxiety and fear of Covid-19 in patients with schizophrenia and BAD and to plan the necessary treatment approaches.